期刊文献+

降钙素的研究进展 被引量:15

原文传递
导出
摘要 目的:了解降钙素的研究进展,为进一步研究和利用提供参考。方法:根据文献,对降钙素的药理作用、临床应用及新剂型等方面的进展进行综述。结果:降钙素具有中枢镇痛的特点;可用于治疗骨髓炎等与骨代谢率升高有关的疾病;现有的新剂型有以脂质体为载体的降钙素给药系统(包括柔性脂质体、前体脂质体等)、聚乙二醇修饰的降钙素等。结论:随着降钙素新作用的发现及其新剂型的发展,使其具有广阔的应用前景。
出处 《中国药房》 CAS CSCD 北大核心 2011年第17期1617-1619,共3页 China Pharmacy
基金 国家高技术研究发展计划(863)资助项目(2007AA02Z171) 国家基础科学人才培养基金资助项目(J0630858)
  • 相关文献

参考文献24

  • 1Purdue BW, Tilakaratne N, Sexton PM. Molecular pharm- acology of the calcitonin receptor[J]. Receptors and Chan- nels, 2002,8(3-4) : 243.
  • 2Shyu JF, Shih C, Tseng CY, et al. Calcitonin induces pod- osome disassembly and detachment of osteoclasts by mod- ulating Pyk2 and Src activities[J]. Bone, 2007, 40 (5) : 1 329.
  • 3Gardner CR. Morphological analysis of osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures [J]. Cell Biology International, 2007, 31 (7) : 672.
  • 4Mancini L, Paul-Clark MJ, Rosignoli G, et al. Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis[J]. Ameri- can Journal of Pathology, 2007,169 ( 3 ) : 1 018.
  • 5Gennari C. Analgesic effect of calcitonin in osteoporosis[J]. Bone, 2002,30 (5) : 67.
  • 6Pecile A. Calcitonin and relief of pain[J]. Bone Miner, 1992, 16 (3) : 187.
  • 7Braga PC. Calcitonin and its antinociceptive activity: ani- mal and human investigations 1975 -- 1992[J]. Agents and Actions, 1994,41(3-4) : 121.
  • 8Sibilia V, Pagani F, Lattuada N, et al. Amylin compared with calcitonin: competitive binding studies in rat brain and anticiceptive activity[J]. Brain Research, 2000, 854 (1-2):79.
  • 9Karsdal MA, Tanko LB, Riis B J, et al. Calcitonin is invo- lved in cartilage homeostasis: is calcitonin a treatment for OA? [J]. Osteoarthritis and Cartilage, 2006, 14 (7) : 617.
  • 10Sondergaard BS, Olsen AK, Sumer EU, et al. Calcitonin stimulates proteoglycan and collagen Type Ⅱ biosynthe- sis in articular cartilage ex vivo[J]. Osteoarthritis and Car- tilage, 2005, 13 (Supplement 1) : S142.

二级参考文献36

  • 1钱德明,沈根全,柯若伦.用大鼠血钙法测定降钙素生物效价的探讨[J].药物分析杂志,1994,14(3):30-34. 被引量:12
  • 2张永莉,施秉银.降钙素的临床应用[J].陕西医学杂志,2005,34(7):835-836. 被引量:4
  • 3王玉,陈世卿,吴琼,曹瑞杰,康学军,赵祥大.邻甲酚酞络合酮分光光度法测定血清钙[J].安徽大学学报(自然科学版),1996,20(1):68-73. 被引量:3
  • 4Symon Z,Peyser A,Tzemach D,et al. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer, 1999,86 ( 1 ) :72-78.
  • 5Heathcote E J, Shiffman ML, Cooksley WG, et al.Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med, 2000, 343 (23):1673-1680.
  • 6Hershfield MS. PEG-ADA replacement therapy for adenosine deaminase deficiency., an update after 8.5 years. Clin Immunol Immunopathol, 1995, 76 (3 Pt2) :S228-S232.
  • 7Holle LM. Pegaspargase :an alternative? Ann Pharmacother, 1997,31 (5) :616-624.
  • 8Davis-Daneshfar A,Boni R,von Wussow P,et al. Adjuvant immunotherapy in malignant melanoma :impact of antibody formation against interferon-alpha on immunoparameters in vivo. J Immunother, 1997,20 (3)208-213.
  • 9Bailon P,Palleroni A,Schaffer CA,et al. Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. Bioconjug Chem, 2001,12(2) : 195-202.
  • 10Zeuzem S, Feinman SV, Rasenack J,et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med,2000,343(23) : 1666-1672.

共引文献14

同被引文献176

引证文献15

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部